1. Sherlock S, Dooley J. Diseases of the Liver and Biliary System. 10th ed. Oxford, Blackwell Scientific Publications, 1997; 265-302.
2. Değertekin H. Viral hepatitlerin dünyada ve ülkemizde epidemiyolojisi. Aktüel Tıp Derg 1997; 2: 119-122.
3. Hoofnagle JH, Shafritz DA, Popper H. Chronic type B hepatitis and the "healthy" HBsAg carrier state. Hepatology 1987; 7: 758-763.
4. Dragosics B, Ferenci P, Hitchman E, Denk H. Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: A clinical and histologic evaluation of 242 cases. Hepatology 1987; 7: 302-306.
5. Popper H, Shafritz DA, Hoofnagle JH. Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology 1987; 7: 764-772. .
6. de Franchis R, Meucci G, Vecchi M, et al. The natural history of asymtomatic hepatitis B surface antigen carriers. Ann Intern Med 1993; 118: 191-194.
7. Villeneuve JP, Desrochers M, Infante-Rivard C; et al. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology 1994; 106: 1000-1005.
8. McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP. Hepatitis B-related sequelae: prospective study iri 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med 1990; 150: 1051-1054:
9. Ökten A, Demir K, Çakaloğlu Y; et al: Kronik asemptomatik HBsAg taşıyıcılığı (372 vakanın değerlendirilmesi). T Klin Gastroenterohepatol 1996; 7: 178-183.
10. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988; 61: 1942-1956.
11. Sakuma K, Saitoh N, Kasai M, et al. Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: a prospective study. Hepatology 1988; 8: 1642-1646.